drugset / Trial / NCT06319872

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

NCT06319872

Phase 1 Recruiting 15 enrolled University of Rochester
NaSequentialOpen-labelTreatment

Summary

Oral disulfiram (Antabuse®) has been shown to improve image-forming vision in animal models with retinal degeneration due to its ability to decrease Retinoic Acid synthesis and consequently reduce hyperactivity in the inner retina. The investigator will aim to evaluate the impact of oral disulfiram on the vision of patients with retinal degeneration who are being treated with the drug in the management of their concurrent alcohol use disorder.

Timeline

Start
2025-05-19
Primary completion
2029-05-19
Completion
2029-05-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Disulfiram Small molecule 250 mg Oral